These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6266500)

  • 21. Survey of nonhuman primates for antibodies reactive with Epstein-Barr virus (EBV) antigens and susceptibility of their lymphocytes for immortalization with EBV.
    Ishida T; Yamamoto K
    J Med Primatol; 1987; 16(6):359-71. PubMed ID: 2828628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus susceptibility of B cells correlates to the presence of complement receptors but not surface immunoglobulins.
    Takada K; Osato T
    Intervirology; 1981; 16(2):118-22. PubMed ID: 6276327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid and steroids inhibit Epstein-Barr virus-induced nuclear antigen, DNA synthesis and lymphocyte transformation.
    Sundar SK; Levine PH; Ablashi DV; Menezes J
    Anticancer Res; 1984; 4(6):415-8. PubMed ID: 6097161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus (EBV)-lymphoid cell interactions. I. Quantification of EBV particles required for the membrane immunofluorescence assay and the comparative expression of EBV receptors on different human B, T and null cell lines.
    Patel P; Menezes J
    J Gen Virol; 1981 Mar; 53(Pt 1):1-11. PubMed ID: 6268736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns.
    Klein G; Zeuthen J; Ber R; Ernberg I
    J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment of T-cell control of Epstein-Barr virus infected B-cells in patients with adult T-cell leukemia.
    Katsuki T; Yamaguchi K; Matsuoka Y; Hinuma Y
    AIDS Res; 1986 Dec; 2 Suppl 1():S125-30. PubMed ID: 3030343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Demonstration of Epstein-Barr virus (EBV)-related antigens and tumorigenicity in nude mice in a hybrid cell line derived from the fusion of an EBV-positive lymphoblastoid cell and an EBV-negative epithelial cell from the human nasopharynx].
    Ishiguro H
    Nihon Jibiinkoka Gakkai Kaiho; 1984 Jun; 87(6):693-707. PubMed ID: 6092593
    [No Abstract]   [Full Text] [Related]  

  • 28. Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes.
    Nussbaum O; Zakai N; Loyter A
    Virology; 1984 Oct; 138(2):185-97. PubMed ID: 6093364
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
    Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S; Dieks D; Sukdolak C; Bunse C; Figueiredo C; Immenschuh S; Borchers S; Stripecke R; Maecker-Kolhoff B; Blasczyk R; Eiz-Vesper B
    J Immunol Methods; 2014 Jun; 408():101-13. PubMed ID: 24877879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Epstein-Barr virus receptor is distinct from the C3 receptor.
    Wells A; Koide N; Stein H; Gerdes J; Klein G
    J Gen Virol; 1983 Feb; 64 (Pt 2)():449-53. PubMed ID: 6300295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
    Delecluse HJ; Feederle R; Behrends U; Mautner J
    Semin Cancer Biol; 2008 Dec; 18(6):409-15. PubMed ID: 18938248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new animal model for primary and persistent Epstein-Barr virus infection: human EBV-infected rabbit characteristics determined using sequential imaging and pathological analysis.
    Takashima K; Ohashi M; Kitamura Y; Ando K; Nagashima K; Sugihara H; Okuno K; Sairenji T; Hayashi K
    J Med Virol; 2008 Mar; 80(3):455-66. PubMed ID: 18205213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus.
    Rosenthal KS; Shuman H; Strominger JL
    J Immunol; 1981 Aug; 127(2):746-54. PubMed ID: 6166685
    [No Abstract]   [Full Text] [Related]  

  • 36. T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis.
    Klein E; Ernberg I; Masucci MG; Szigeti R; Wu YT; Masucci G; Svedmyr E
    Cancer Res; 1981 Nov; 41(11 Pt 1):4210-5. PubMed ID: 6272964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization.
    Wolf BC; Martin AW; Neiman RS; Janckila AJ; Yam LT; Caracansi A; Leav BA; Winpenny R; Schultz DS; Wolfe HJ
    Am J Pathol; 1990 Mar; 136(3):717-23. PubMed ID: 2156435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion of Sendai virus with the target cell membrane is required for T cell cytotoxicity.
    Gething M; Koszinowski U; Waterfield M
    Nature; 1978 Aug; 274(5672):689-91. PubMed ID: 209339
    [No Abstract]   [Full Text] [Related]  

  • 40. The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.
    Thorley-Lawson DA
    J Immunol; 1980 Feb; 124(2):745-51. PubMed ID: 6243331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.